European Pharmaceutical Review

OCTOBER 19, 2023

billion deal, in which Eli Lilly agreed to acquire two of POINT Biopharma Global’s late-stage radioligand therapies for oncological indications. Can you share an update on the clinical trial for your lead candidate? Hoppin served as lead director of Noria as the two organisations were sold to Bayer Healthcare in June of 2021.

Food and Drug Administration 90

Food and Drug Administration Side effects Manufacturing Doctors 90

Clarivate

AUGUST 17, 2022

Inadequate health services can have devastating consequences, especially when it comes to non-communicable diseases (NCD) , such as cardiovascular diseases, cancers and diabetes, which is the leading cause of death globally. Dr. Grace Lomax : Yes, happily. We also threaded into it information that they needed to know.

Healthcare 52

Healthcare Healthcare Patients Physicians 52

PM360

JUNE 11, 2022

Regardless of the tactics and strategies employed, I would encourage more biopharma professionals to get personally involved in patient engagement programs. Typically, we think of patient partnerships in terms of their external impact—for example, to help educate doctors and payers. A Patient-Centric Month Leads to Results.

Patients 59

Patients Pharma Education Media 59